Science where evidence meets consequence.
Discovery follows science where evidence is still being tested, from dark oxygen claims in the Pacific Ocean to antibiotic resistance and altered speech after stroke. Its recent episodes favour patient reporting, named examples, and the friction between discovery, doubt, money, medicine, and identity.
PRESS PLAY
Discovery is a BBC science programme about evidence under pressure. It is less interested in wonder as a mood than in what happens after a claim, a crisis, or a mystery asks to be tested. Recent episodes travel widely: dark oxygen reported from the deep Pacific Ocean, antibiotic resistance in hospitals, chemical tools for detecting art forgery, an altered accent after stroke, Hurricane Katrina at an earth-science gathering, and a data story that begins with hunger in the Netherlands. The range is broad, but the method is consistent. A scientific question is placed inside a real situation, then examined through people, places, measurements, and consequences. That gives the show a grounded feel. It can handle large claims without turning them into spectacle. The dark oxygen episode, for example, sits with the appeal of a startling seabed finding and the sharp criticisms that followed. The antibiotic resistance run connects laboratory work, hospital risk, drug development, and the economic problem of getting new antibiotics to patients. In the art-forgery conversation with Jihan Ragai, chemistry becomes a way to read materials, pigments, mortars, and authenticity. In the episode with Althea Bryden, neurological change is also a question of identity. Discovery often works best at this boundary, where science is exacting but the implications are personal. Its pacing is explanatory and investigative, with room for technical detail when the subject needs it. The show does not require every story to end neatly. It lets a listener hear uncertainty, disagreement, and unfinished work without losing the thread. That makes it useful for people who want science reporting with stakes, not just facts arranged into a lesson. Across recent episodes, Discovery offers science as an active practice: argued over, funded, measured, challenged, and sometimes lived through in the body.
Made for: Suits a listener who wants rigorous science stories with human stakes, careful context, and room for uncertainty. It fits people drawn to medicine, earth science, chemistry, neuroscience, and disputed discoveries.
What sets it apart: Discovery stands apart by staying close to the machinery of science: methods, criticism, funding, reporting, and the people affected by the results. It makes room for both technical detail and the emotional weight of what those details mean.
Explorations in the world of science.
Bed rails harbor resistant bacteria; Roland Pease takes you into the money problem behind new antibiotics.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A deep-ocean oxygen claim becomes a tense, clear test of startling evidence under public scrutiny.
Dark Breath revisits a striking claim: oxygen had been detected 4,000 metres beneath the Pacific, far beyond the reach of sunlight. The episode tracks the rush of interest around that possibility, then gives space to the pushback from Michael, who says the evidence does not bear…
A clear, grounded look at why antibiotic resistance can move fast while new drugs remain hard to bring to market.
Discovery frames carbapenem-resistant infections as a problem of systems, money, and bad timing, not just microbiology. The episode moves from Greek intensive care units to the broader threat of resistance, then follows the uneasy economics behind new antibiotics through Kenneth…
A sober look at antibiotic discovery, from lab chemistry to the financial pressures that can stall new drugs.
Discovery tracks the hunt for antibiotics able to stay ahead of resistant bacteria, moving from a child given linezolid on compassionate-use grounds to Steve Brickner's account of shepherding a new medicine into the world.
A stark account of how hospital bacteria can turn intensive care into a life-threatening race against resistance.
Antibiotic resistance is framed as a medical threat with an immediate human scale: an otherwise healthy 42-year-old woman develops pneumonia in intensive care after skidding on a wet road, then dies from an infection resistant to almost all available antibiotics, with colistin…
A chemistry-led life story linking art forgery, ancient mortar, archaeology, and resilience.
Art forgery gives The Life Scientific a sharp way into Jihan Ragai's work, framing chemistry as something practical, investigative, and quietly dramatic.
Particle accelerators, compost piles and Queen's guitarist, all explained.
Steven Novella and a rotating panel dissect weekly science news and debunk pseudoscience claims.
APA's Kim Mills interviews psychology researchers on tipping, crying, and extremism.
Professor Tim Coulson discusses how a near-death experience with malaria sparked his obsession with understanding how animals and plants survive or die in nature.
A reflection on Hurricane Katrina's lessons at the AGU fall meeting, emphasizing the social science challenge of acting on known risks.
Jane Goodall recounts her groundbreaking research on wild chimpanzees in Gombe and her lifelong advocacy for animal welfare and conservation.
This episode explores how tulip bulbs used as food during the WWII Dutch famine unexpectedly helped children with G-Hurter's Syndrome, leading to a medical discovery linked to bananas.
Victoria Gill opens with a 2024 email about “evidence of dark oxygen production at the abyssal seafloor,” a claim that oxygen was being made in complete darkness 4,000 metres down.
Roland Pease traces why Achaogen's antibiotic plasmacin reached U.S.
BBC World Service’s Discovery tracks the antibiotic arms race from linezolid’s 2000 launch to the rise of plasmid-borne resistance genes such as CFR, Piox-TA, and OPTRA.
Roland Pease opens at the Dunn School of Pathology in Oxford, where Howard Florey, Ernst Chain and colleagues first isolated and purified penicillin between 1938 and 1941.
Discovery’s The Life Scientific: Jehane Ragai follows Jihan Ragai from Cairo chemistry to art-forgery detection, beginning with Han van Meegeren and a Vermeer that fooled experts and the Nazis.
Tony Juniper, chair of Natural England, argues that nature recovery is tied to human well-being, food security, and the economy.
Pierre Friedlingstein estimates that the remaining budget for 1.5 degrees equals about five years of current emissions.
Julia Simner estimates at least 4.4% of people have synesthesia, or about one in 23.
A science journalist explores the story of a woman who developed foreign accent syndrome after a stroke, changing her accent and identity.